Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PfSPZ Vaccine in Tanzanian Adults, Children, and Infants
NCT02613520Phase 1Completed
- Sponsor
- Sanaria Inc.
- Start
- Dec 2015
- Primary completion
- Feb 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Sanaria PfSPZ Vaccine in malaria (23 arms), sponsored by Sanaria Inc. Primary endpoint: Incidence and type of Adverse Events. Started Dec 2015; status: completed.
02
Drugs
Sanaria PfSPZ Vaccine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02613520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02613520.